210 related articles for article (PubMed ID: 15625612)
21. Severe rhabdomyolysis as a consequence of the interaction of fusidic acid and atorvastatin.
Magee CN; Medani SA; Leavey SF; Conlon PJ; Clarkson MR
Am J Kidney Dis; 2010 Nov; 56(5):e11-5. PubMed ID: 20888103
[TBL] [Abstract][Full Text] [Related]
22. Development of tachyphylaxis on statin treatment.
Miserez AR; Keller U; Mirsaidi R
Am J Cardiol; 2001 Oct; 88(8):936-7. PubMed ID: 11676971
[No Abstract] [Full Text] [Related]
23. Atorvastatin for stroke prevention.
Med Lett Drugs Ther; 2006 Sep; 48(1243):75-6. PubMed ID: 16977287
[No Abstract] [Full Text] [Related]
24. Statin-induced rhabdomyolysis and dermatomyositis: a rare combination.
Cannon CS
JAAPA; 2012 Aug; 25(8):30, 32-3. PubMed ID: 22928274
[No Abstract] [Full Text] [Related]
25. Hypernatremia due to rhabdomyolysis in a patient on statin.
Victor SM; Gnanaraj A; Abraham G; Sankardas MA
Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1037-8. PubMed ID: 21912045
[No Abstract] [Full Text] [Related]
26. Safety of statin therapy in patients with mitochondrial diseases.
Hannah-Shmouni F; Al-Sarraf A; Frohlich J; Mezei MM; Sirrs S; Mattman A
J Clin Lipidol; 2013; 7(2):182. PubMed ID: 23415441
[No Abstract] [Full Text] [Related]
27. Atorvastatin pleiotropic effects mediated via suppression of TNF-alpha in congestive heart failure patients with initial normal TNF-alpha levels.
Kotyla PJ
J Heart Lung Transplant; 2009 Jan; 28(1):114-5. PubMed ID: 19134543
[No Abstract] [Full Text] [Related]
28. Summaries for patients. Treatment trials to determine whether statins are the cause of a patient's discomfort.
Ann Intern Med; 2014 Mar; 160(5):I-34. PubMed ID: 24737270
[No Abstract] [Full Text] [Related]
29. Effects of atorvastatin and atorvastatin withdrawal on soluble CD40L and adipocytokines in patients with hypercholesterolaemia.
Chu CS; Lee KT; Lee MY; Su HM; Voon WC; Sheu SH; Lai WT
Acta Cardiol; 2006 Jun; 61(3):263-9. PubMed ID: 16869445
[TBL] [Abstract][Full Text] [Related]
30. [Metabolic rhabdomyolysis during statin therapy].
Vergely N; Leca V; Antoine JC; Germain N; Khalfallah Y; Estour B
Rev Med Interne; 2009 Aug; 30(8):711-3. PubMed ID: 19419805
[TBL] [Abstract][Full Text] [Related]
31. Atorvastatin in the treatment of primary hypercholesterolemia and mixed dyslipidemias.
Yee HS; Fong NT
Ann Pharmacother; 1998 Oct; 32(10):1030-43. PubMed ID: 9793596
[TBL] [Abstract][Full Text] [Related]
32. Rhabdomyolysis with atorvastatin and fusidic acid.
O'Mahony C; Campbell VL; Al-Khayatt MS; Brull DJ
Postgrad Med J; 2008 Jun; 84(992):325-7. PubMed ID: 18644925
[TBL] [Abstract][Full Text] [Related]
33. [Myopathy due to deficiency of desaminase myoadenilate induced by atorvastatine].
García-Estévez DA; San Millán B; Navarro C; Sogo T
Med Clin (Barc); 2013 Jun; 140(12):565-7. PubMed ID: 23337446
[No Abstract] [Full Text] [Related]
34. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
35. Acute rhabdomyolysis after atorvastatin and fusidic acid therapy.
Wenisch C; Krause R; Fladerer P; El Menjawi I; Pohanka E
Am J Med; 2000 Jul; 109(1):78. PubMed ID: 10991749
[No Abstract] [Full Text] [Related]
36. Statin-associated acute interstitial nephritis and rhabdomyolysis.
Panchangam V
Saudi J Kidney Dis Transpl; 2014 May; 25(3):659-60. PubMed ID: 24821172
[No Abstract] [Full Text] [Related]
37. Atorvastatin-related rhabdomyolysis and acute renal failure in a genetically predisposed patient with potential drug-drug interaction.
Marusic S; Lisicic A; Horvatic I; Bacic-Vrca V; Bozina N
Int J Clin Pharm; 2012 Dec; 34(6):825-7. PubMed ID: 23076661
[TBL] [Abstract][Full Text] [Related]
38. Benefits and menaces related to the use of statins in patients after renal transplantation.
Chmielewski M; Zdrojewski Z; Rutkowski B
Ann Transplant; 2002; 7(2):6-10. PubMed ID: 12416466
[TBL] [Abstract][Full Text] [Related]
39. Acute hepatic injury with atorvastatin: an unusual occurrence.
Vishwakarma P; Nehra R; Kumar A
Indian J Pharmacol; 2014; 46(3):343-4. PubMed ID: 24987187
[TBL] [Abstract][Full Text] [Related]
40. Causal structures for evaluating statin class effects.
Seeger JD
Ann Pharmacother; 2002 Dec; 36(12):1961-5. PubMed ID: 12494951
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
